Skip to content
Screener

Xtant Medical Holdings XTNT Q2 2026 earnings

Reported August 11, 2026 · Before market open

Revenue$23.0MMiss by $1.8M
EPS-$0.07Miss by $0.05
Revenue estimate$24.9M
EPS estimate-$0.02
“The second quarter reflected continued execution of our strategy to broaden our core biologics portfolio while expanding access to more hospitals and surgeons. The Dilon distribution agreement added a complementary hemostatic technology and significant commercial resources, which, together with the introduction of Trivium Shaped, strengthen our platform and position us for sustained long-term growth.”
Sean Browne

Next report

Nov 10, 2026 (in 2 months)
Revenue estimate$25.5M
EPS estimate-$0.03

Financials

Q2 2026

Income statement

See full
Revenue$23.0M-35.0%
Gross profit$13.3M-45.1%
Operating income-$9.2M-298%
Net income-$9.4M-365%
EPS (diluted)-$0.07-450%

Balance sheet

See full
Cash & equivalents$10.2M+45.2%
Total debt$14.0M-44.0%
Total equity$40.0M-17.5%
Total assets$79.7M-23.0%

Cash flow

See full
Operating cash flow-$7.3M-673%
CapEx$247.0K-32.5%
Free cash flow-$7.6M-930%

Valuation & ratios

Valuation

as of 09/17/26
See full
Market cap$44.89M-50.7%
Enterprise value$48.7M-55.3%
P/S0.4×-0.3×

Profitability

See full
Gross margin59.4%-0.8pp
Net margin-10.2%-22.3pp
FCF margin-0.6%-0.3pp

Returns & leverage

See full
Return on equity-25.2%-69.5pp
Debt / equity0.4×-0.2×
Current ratio2.2×-0.3×

Segments

By product

See full
Orthobiologics$17.4M-10.4%
Spinal Implant$5.7M-48.8%

FAQ

When did Xtant Medical Holdings report Q2 2026 earnings?
Xtant Medical Holdings (XTNT) reported Q2 2026 earnings on August 11, 2026 before market open.
What were Xtant Medical Holdings's Q2 2026 revenue and EPS?
Xtant Medical Holdings reported revenue of $23.0M and eps of $-0.07 for Q2 2026.
Did Xtant Medical Holdings beat estimates in Q2 2026?
Revenue missed the consensus estimate of $24.9M by $1.8M. EPS missed the consensus estimate of $-0.02 by $0.05.
How did Xtant Medical Holdings's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 35.0% from $35.4M a year earlier.
Where can I find Xtant Medical Holdings's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001493152-26-036979) and the 10-Q periodic report (0001493152-26-036981) directly on SEC EDGAR. The filing index links above go to sec.gov.